2026. Analysis of the degree of fibrosis in patients with steatotic liver disease associated with metabolic dysfunction (MASLD) using FibroScan®. Electronic Journal Collection Health. 26, 1 (Jan. 2026), e22602. DOI:https://doi.org/10.25248/reas.e22602.2026.